Mr. Ronald Ede is the Executive Directors & Chief Financial Officer for Innovent Biologic Inc. Joined since 2017, Mr. Ede is responsible for finance, investor relations, fund, channel management and information technology of the Group.
Prior to joining the Group, from 2011 to 2016, Mr. Ede was the chief financial officer of Biosensors International Ltd. and from 2009 to 2011, he was the executive director and chief financial officer of Mindray Medical International Limited.
Mr. Ede is also an independent non-executive director for Mindray Medical International Limited (a listed company on the Shenzhen Stock Exchange with stock code: 300760) since 2006, and Dawnrays Pharmaceutical (Holding) Ltd. (a company listed on the Hong Kong Stock Exchange with stock code: 2348) since 2015, respectively.
Mr. Ede received his bachelor of business administration degree from University of Hawaii in December 1984 and master of business administration degree from University of Washington in December 1988. Mr. Ede is a fellow member of the Institute of Singapore Chartered Accountants and an A-Share independent director certified by the Shenzhen Stock Exchange.